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The Editors-in-Chief and Publisher have retracted this 
article [1] because the scientific integrity of the content 
cannot be guaranteed. An investigation by the Publisher 
found it to be one of a group of articles we have identified 
as showing evidence suggestive of attempts to subvert the 
peer review and publication system to inappropriately 
obtain or allocate authorship. This article showed evi-
dence of plagiarism (most notably from the articles cited 
[2, 3]) and authorship manipulation.
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